List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 61 studies with search of:   Open Studies | "Medulloblastoma"
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma
Conditions: Neuroblastoma;   Medulloblastoma
Interventions: Drug: Nifurtimox;   Drug: Cyclophosphamide;   Drug: Topotecan;   Drug: Zolendronic acid
2 Recruiting Combination of Irinotecan and Temozolomide in Children With Brain Tumors.
Conditions: Glioma;   Medulloblastoma
Interventions: Drug: Irinotecan;   Drug: Temozolomide
3 Recruiting Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With Medulloblastoma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: cisplatin;   Drug: iodine I 131 monoclonal antibody 3F8;   Drug: lomustine;   Drug: vincristine sulfate;   Procedure: adjuvant therapy;   Procedure: radiation therapy
4 Recruiting Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Metastatic Medulloblastoma Who Have Undergone Surgery
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: cisplatin;   Drug: lomustine;   Drug: vincristine sulfate;   Procedure: adjuvant therapy;   Procedure: radiation therapy
5 Recruiting Low-Dose Radiation Therapy and Combination Chemotherapy Following Surgery in Treating Children With Newly Diagnosed Primitive Neuroectodermal Tumor or Medulloblastoma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: cisplatin;   Drug: cyclophosphamide;   Drug: etoposide;   Drug: lomustine;   Drug: vincristine sulfate;   Procedure: adjuvant therapy;   Procedure: radiation therapy
6 Recruiting Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: cisplatin;   Drug: cyclophosphamide;   Drug: lomustine;   Drug: vincristine sulfate;   Procedure: radiation therapy
7 Recruiting Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: carboplatin;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: etoposide;   Drug: leucovorin calcium;   Drug: methotrexate;   Drug: thiotepa;   Drug: vincristine sulfate
8 Recruiting Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: carboplatin;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: etoposide phosphate;   Drug: lomustine;   Drug: methotrexate;   Drug: thiotepa;   Drug: vincristine sulfate;   Procedure: high-dose chemotherapy;   Procedure: radiation therapy
9 Recruiting Proton Beam Radiation Therapy in Treating Young Patients Who Have Undergone Biopsy or Surgery for Medulloblastoma or Pineoblastoma
Conditions: Brain and Central Nervous System Tumors;   Cancer-Related Problem/Condition
Interventions: Procedure: adjuvant therapy;   Procedure: cognitive assessment;   Procedure: management of therapy complications;   Procedure: radiation therapy
10 Not yet recruiting GDC-0449 in Treating Young Patients With Medulloblastoma That is Recurrent or Did Not Respond to Previous Treatment
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: Hedgehog antagonist GDC-0449;   Procedure: gene expression analysis;   Procedure: in situ hybridization;   Procedure: laboratory biomarker analysis;   Procedure: pharmacological study;   Procedure: reverse transcriptase-polymerase chain reaction
11 Recruiting Radiation Therapy and Combination Chemotherapy Followed by Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: cisplatin;   Drug: cyclophosphamide;   Drug: filgrastim;   Drug: vincristine sulfate;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: radiation therapy
12 Recruiting Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: carboplatin;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: filgrastim;   Drug: isotretinoin;   Drug: vincristine sulfate;   Procedure: radiation therapy
13 Recruiting Immuno 1: Immune Reconstitution Following Conventional or High-Dose Chemotherapy With Stem Cell Transplant
Conditions: Leukemia;   Medulloblastoma
Intervention:
14 Recruiting Clinical Studies of Gemcitabine-Oxaliplatin
Conditions: Medulloblastoma;   Central Nervous System Tumors;   Neuroblastoma;   Osteosarcoma
Intervention: Drug: Gemcitabine (Gemzar®), Oxaliplatin (Eloxatin®)
15 Recruiting A Study of Pemetrexed in Children With Recurrent Cancer
Conditions: Osteosarcoma;   Medulloblastoma;   Sarcoma, Ewings;   Neuroblastoma
Intervention: Drug: pemetrexed
16 Recruiting High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood
Conditions: Medulloblastoma;   Brain Tumors;   Neuroectodermal Tumors, Primitive
Intervention: Drug: Etoposide, carboplatin, melphalan, cisplatin, thiotepa
17 Recruiting Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: bevacizumab;   Drug: fludeoxyglucose F 18;   Drug: irinotecan hydrochloride;   Procedure: magnetic resonance imaging;   Procedure: positron emission tomography
18 Recruiting Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children
Conditions: Recurrent Brain Tumors;   Supratentorial PNETs;   Medulloblastomas;   Ependymomas
Interventions: Drug: carboplatin;   Drug: etoposide;   Drug: temozolomide;   Drug: thiotepa, carboplatin, etoposide;   Drug: temozolomide, thiotepa;   Procedure: autologous stem cell transplantation;   Drug: etoposide;   Drug: trofosfamid/etoposide
19 Recruiting Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse
Conditions: Rhabdomyosarcomas;   Neoplasms, Connective and Soft Tissue;   Ewing Tumor;   Osteosarcomas;   Neuroblastomas;   Medulloblastomas
Intervention: Drug: Vinorelbine, cyclofosfamide
20 Recruiting Neuropsychological and Behavioral Testing in Young Patients With Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor (PNET)
Conditions: Brain and Central Nervous System Tumors;   Cancer-Related Problem/Condition
Interventions: Procedure: cognitive assessment;   Procedure: psychosocial assessment and care;   Procedure: quality-of-life assessment;   Procedure: questionnaire administration

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services